Barclays’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $729K | Sell |
|
|||||
|
2025
Q1 | $958K | Sell |
|
|||||
|
2024
Q4 | $1.62M | Buy |
|
|||||
|
2024
Q3 | $959K | Buy |
|
|||||
|
2024
Q2 | $396K | Buy |
|
|||||
|
2024
Q1 | $700K | Sell |
|
|||||
|
2023
Q4 | $594K | Sell |
|
|||||
|
2023
Q3 | $2.5M | Buy |
|
|||||
|
2023
Q2 | $3.33M | Buy |
|
|||||
|
2023
Q1 | $2.47M | Buy |
|
|||||
|
2022
Q4 | $2.66M | Buy |
|
|||||
|
2022
Q3 | $3.43M | Buy |
|
|||||
|
2022
Q2 | $350K | Sell |
|
|||||
|
2022
Q1 | $951K | Buy |
|
|||||
|
2021
Q4 | $1.5M | Buy |
|
|||||
|
2021
Q3 | $1.12M | Sell |
|
|||||
|
2021
Q2 | $2.5M | Sell |
|
|||||
|
2021
Q1 | $4.57M | Buy |
|
|||||
|
2020
Q4 | $1.55M | Sell |
|
|||||
|
2020
Q3 | $2.99M | Sell |
|
|||||
|
2020
Q2 | $3.79M | Buy |
|
|||||
|
2020
Q1 | $1.2M | Buy |
|
|||||
|
2019
Q4 | $1.25M | Buy |
|
|||||
|
2019
Q3 | $870K | Buy |
|
|||||
|
2019
Q2 | $671K | Sell |
|
|||||
|
2019
Q1 | $868K | Buy |
|
|||||
|
2018
Q4 | $27K | Buy |
|